Rachel E. Rutkowski

Sibling Recurrence Risk of Non‐Chromosomal Birth Defects: A Population‐Based Study in Florida, 2000–2019

Rachel E. Rutkowski, Jean Paul Tanner, Amanda L. Elmore, Russell S. Kirby et autres

OBJECTIVES: To estimate sibling recurrence risk for non-chromosomal birth defects using statewide, population-based data. METHODS: We analyzed data from the Florida Birth Defects Registry to identify singleton siblings born 2000-2019 with any of 43 non-chromosomal birth defects. Multivariable logistic regression was used …

us (code pays fourni par la source)

Hospitalization Outcomes of Full-Term and Premature Children Aged Less Than 2 Years Hospitalized With RSV

Abigail Salthouse, Ayzsa Tannis, Rachel E. Rutkowski, Geoffrey A. Weinberg et autres

BACKGROUND: Prematurity may place young children at increased risk for severe respiratory syncytial virus (RSV) disease because of differences in lung development. We describe characteristics of children aged less than 2 years hospitalized with RSV by prematurity and bronchopulmonary dysplasia (BPD) status …

us (code pays fourni par la source)

Validation of ICD-9-CM and ICD-10-CM Diagnosis Codes for Identifying Preterm Birth and Low Birthweight Infants in Florida Birth Hospitalizations, 2008-2018.

Rachel E. Rutkowski, Jean Paul Tanner, Scott D. Grosse, Norman J. Waitzman et autres

Objective: To estimate the sensitivity and positive predictive value (PPV) of ICD-9-CM and ICD-10-CM diagnosis codes for identifying preterm birth (PTB) and low birthweight (LBW) infants in birth hospital discharge data, using birth certificate records as the reference standard. Methods: , Ninth …

us (code pays fourni par la source)

Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children

Heidi L. Moline, Ayzsa Tannis, Leah Goldstein, Janet A. Englund et autres

Importance: During the 2024-2025 respiratory syncytial virus (RSV) season in the US, nirsevimab and maternal RSV vaccination became widely available to prevent severe RSV disease in infants. Assessments of the real-world effectiveness and impact of both products are needed to inform RSV …

us (code pays fourni par la source)

Comparison of immunization information systems, electronic medical records, and self-report to ascertain RSV vaccination status among US adults aged ≥60 years, 2023–2024

Lauren T Vanasse, Basmah Safdar, Wesley H. Self, Yuwei Zhu et autres

us (code pays fourni par la source)

Clinical Testing for COVID-19, Influenza, and RSV in Hospitalized Youths, 2016-2024

Ariana P. Toepfer, Rachel E. Rutkowski, Leila C. Sahni, Geoffrey A. Weinberg et autres

Importance: Studies of COVID-19, influenza, and respiratory syncytial virus (RSV) disease clinical epidemiology, disease burden, and vaccine effectiveness often rely on clinical testing to identify cases, particularly with increasing use of electronic health record data. However, few data are available describing clinical …

us (code pays fourni par la source)

RSV Vaccine Effectiveness Against Hospitalization Among US Adults Aged 60 Years or Older During 2 Seasons

Diya Surie, Wesley H. Self, Katharine A. Yuengling, Adam S. Lauring et autres

Importance: Respiratory syncytial virus (RSV) vaccines for adults aged 60 years or older became available in 2023. One dose is recommended for all adults aged 75 years or older and those aged 60 to 74 years at increased risk of severe RSV; …

us (code pays fourni par la source)

Patient- and Community-Level Characteristics Associated With Respiratory Syncytial Virus Vaccination

Diya Surie, Katharine A. Yuengling, Basmah Safdar, Adit A. Ginde et autres

Importance: In 2023, the first respiratory syncytial virus (RSV) vaccines were recommended for US adults 60 years or older, but few data are available about which patients were most likely to receive vaccine to inform future RSV vaccine outreach efforts. Objective: To …

us (code pays fourni par la source)

Diabetes Distress Among US Adults With Diagnosed Diabetes, 2021

Dayna S. Alexander, Ryan Saelee, Betsy Rodríguez, Alain K. Koyama et autres

National prevalence of diabetes distress is unknown among US adults. This cross-sectional study examined the prevalence among US adults with diabetes using 2021 National Health Interview Survey data. Multivariable multinomial logistic regressions were used to estimate adjusted prevalence and prevalence ratios for …

us (code pays fourni par la source)

702-P: Prescription Medication Use for Treatment of Mental Health Conditions among Adults With and Without Diabetes, 1999–2020

Rachel E. Rutkowski, KAI M. BULLARD, DEBORAH B. ROLKA

Introduction & Objective: Mental health conditions, such as depression and anxiety, can adversely affect one’s quality of life. Prescription medication and other therapeutic measures are often needed for treatment. The purpose of this study is to estimate the prevalence and trends of …

National population‐based estimates for major birth defects, 2016–2020

Erin B. Stallings, Jennifer Isenburg, Rachel E. Rutkowski, Russell S. Kirby et autres

BACKGROUND: We provide updated crude and adjusted prevalence estimates of major birth defects in the United States for the period 2016-2020. METHODS: Data were collected from 13 US population-based surveillance programs that used active or a combination of active and passive case …

us (code pays fourni par la source)

Risk of Cardiovascular Disease After COVID‐19 Diagnosis Among Adults With and Without Diabetes

Alain K. Koyama, Giuseppina Imperatore, Deborah B. Rolka, Elizabeth A. Lundeen et autres

Background Growing evidence suggests incident cardiovascular disease (CVD) may be a long-term outcome of COVID-19 infection, and chronic diseases, such as diabetes, may influence CVD risk associated with COVID-19. We evaluated the postacute risk of CVD >30 days after a COVID-19 diagnosis …

us (code pays fourni par la source)